FFA
BPMC

Farther Finance Advisors’s Blueprint Medicines BPMC Stock Holding History

Farther Finance Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,928
Closed -$503K – 4973
2025
Q2 		$503K Buy
3,928
+3,862
+5,852% +$401K 0.01% 906
2025
Q1 		$5.67K Buy
66
+20
+43% +$1.95K ﹤0.01% 2997
2024
Q4 		$4.01K Sell
46
-1
-2% -$92 ﹤0.01% 2755
2024
Q3 		$4.35K Sell
47
-10
-18% -$993 ﹤0.01% 2700
2024
Q2 		$6.22K Buy
57
+28
+97% +$2.8K ﹤0.01% 2295
2024
Q1 		$2.8K Buy
29
+5
+21% +$429 ﹤0.01% 2349
2023
Q4 		$2.21K Buy
24
+18
+300% +$1.17K ﹤0.01% 2394
2023
Q3 		$301 Hold
6
– – ﹤0.01% 2379
2023
Q2 		$379 Hold
6
– – ﹤0.01% 2227
2023
Q1 		$270 Buy
6
+3
+100% +$135 ﹤0.01% 2145
2022
Q4 		$131 Buy
+3
New +$144 ﹤0.01% 2109

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farther Finance Advisors's BPMC Position: Q3 2025 in Review

Farther Finance Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 3,928 shares — an estimated $503K sold.

Farther Finance Advisors first reported a position in BPMC in Q4 2022 and held it in 11 quarters. The position peaked at $503K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Farther Finance Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 3,928 Blueprint Medicines shares in Q3 2025, an estimated $503K.
  • Farther Finance Advisors first reported a position in Blueprint Medicines in Q4 2022 and held it in 11 quarters.
  • Farther Finance Advisors's Blueprint Medicines position peaked at $503K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.